Process for forming amorphous atorvastatin calcium

Details for Australian Patent Application No. 2005232959 (hide)

Owner Pfizer Products Inc.

Inventors Rose, Peter Robert; Leonard, Jason Albert

Agent Spruson & Ferguson

Pub. Number AU-A-2005232959

PCT Pub. Number WO2005/100313

Priority 60/562,948 16.04.04 US

Filing date 4 April 2005

Wipo publication date 27 October 2005

International Classifications

C07D 207/34 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

Event Publications

16 November 2006 PCT application entered the National Phase

  PCT publication WO2005/100313 Priority application(s): WO2005/100313

14 January 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005232961-Thio-substituted arylmethanesulfinyl derivatives

2005232957-Method and apparatus for hydration of a particulate or pulverulent material containing CaO, hydrated product, and use of the hydrated product